New brain bleed treatment could reduce need for repeat surgery
NCT ID NCT07541404
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new device (NeoCast) that blocks a specific artery in the brain to treat a type of bleeding called subdural hematoma. The goal is to see if it works as well as or better than an existing treatment (Onyx) to prevent the blood from coming back or needing another surgery. About 360 adults with symptoms like headache or confusion will be enrolled.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBDURAL HEMATOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Washington Medicine - Harborview Medical Center
Seattle, Washington, 98104, United States
-
Yale Neurosciences Institute
New Haven, Connecticut, 06519, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Cold plasma zaps brain bleed comeback risk in small trial
- Cheap Blood-Clot drug could cut repeat brain surgery risk
- Massive study aims to predict brain surgery success
- New procedure aims to stop brain bleeds from coming back
- Brain bleed breakthrough? new study tests artery blocking to avoid surgery
- Can a medical glue stop repeat brain bleeds? new study seeks answers.